200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 81382-52-7
81382-52-7 | Imidazo(2,1-b)(1,3,5)benzothiadiazepine, 5-(4-methyl-1-piperazinyl)-, (Z)-2-butenedioate(1
CAS No: 81382-52-7 Catalog No: AG00GEXS MDL No:
Product Description
Catalog Number:
AG00GEXS
Chemical Name:
Imidazo(2,1-b)(1,3,5)benzothiadiazepine, 5-(4-methyl-1-piperazinyl)-, (Z)-2-butenedioate(1
CAS Number:
81382-52-7
IUPAC Name:
(Z)-but-2-enedioic acid;5-(4-methylpiperazin-1-yl)imidazo[2,1-b][1,3,5]benzothiadiazepine
InChI:
InChI=1S/C15H17N5S.C4H4O4/c1-18-8-10-19(11-9-18)14-17-12-4-2-3-5-13(12)21-15-16-6-7-20(14)15;5-3(6)1-2-4(7)8/h2-7H,8-11H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-
InChI Key:
VVNCUDFIJWCVHI-BTJKTKAUSA-N
UNII:
Z5P36MQ43L
Properties
Complexity:
526
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1
Exact Mass:
415.131g/mol
Formal Charge:
0
Heavy Atom Count:
29
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
415.468g/mol
Monoisotopic Mass:
415.131g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
137A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice. | PloS one 20120101 |
| The dopamine release inhibitor CGS 10746B blocks conditioned physical signs of morphine withdrawal. | Addiction biology 20030601 |
| Effects of CGS 10746B on hyperactivity and place preference induced by morphine. | Behavioural brain research 20011129 |
Related Products
© 2019 Angene International Limited. All rights Reserved.